Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for exonucleases
Most Correlated Studies
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- Hearts of mice with Trex1 and Tmem173 (STING) knockout
Most Relevant Literature
- Using Exonucleases for Aptamer Characterization, Engineering, and Sensing.
- Heterozygous Apex1 deficiency exacerbates lipopolysaccharide-induced systemic inflammation in a muri…
- APEX1 in intestinal epithelium triggers neutrophil infiltration and intestinal barrier damage in ulc…
- Exonucleases: Degrading DNA to Deal with Genome Damage, Cell Death, Inflammation and Cancer.
- Lysosomal endonuclease RNase T2 and PLD exonucleases cooperatively generate RNA ligands for TLR7 act…
Most Relevant Clinical Trials
- Avelumab Plus 5-FU Based Chemotherapy as Adjuvant Treatment for Stage 3 MSI-High or POLE Mutant Colo…
- Cohort of Tumors With POLE/D1 Mutation
- Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types
- Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral Leukodystrophy
- Blood Biomarkers in Suicidal Behaviour
